Latest Nature Biotechnology Stories
Scientists have improved upon their own previous world-best efforts to pluck out just the right stem cells to address the brain problem at the core of multiple sclerosis and a large number of rare, fatal children’s diseases.
Massachusetts General Hospital (MGH) researchers – along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals – have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions.
A slight change in molecular structure introduced by genetic engineering gives crop-protecting proteins called Bt toxins a new edge in overcoming resistance of certain pests, a UA-led team of researchers reports in Nature Biotechnology.
Two heat-loving fungi, often found in composts that self-ignite without flame or spark, could soon have new vocations.
The nation's Renewable Fuels Standard calls for annual production of 36 billion gallons of biofuel by 2022. One of the biggest hurdles to achieving this goal lies in optimizing the multistep process involved in breaking down plant biomass and then converting it into fermentable sugars that can be refined into fuel for our transportation needs.
Breakthrough to allow scientists to assemble genomes for thousands of bacteria species that previously couldn't be studied.
For decades, scientists have studied a laboratory mouse model that develops signs of the paralyzing disease amyotrophic lateral sclerosis (ALS) as they age.
A new resource to define the roles of microRNAs is announced today in Nature Biotechnology.
A Purdue University scientist is urging federal officials to decide whether genetically engineered salmon would be allowed for U.S. consumption and arguing that not doing so may set back scientific efforts to increase food production.
The study on single-nucleotide resolution structural variations (SVs) of an Asian and African genome was published online in Nature Biotechnology.